Impact of Chronic Kidney Disease on Decision Making and Management in Transcatheter Aortic Valve Interventions
Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved..
The coexistence of chronic kidney disease (CKD) and severe aortic stenosis (AS) is common, and the prevalence of both is rising. The 2 conditions are inherently linked in that significant CKD may accelerate the development of AS and severe AS may result in deteriorating kidney function. The volume of and indications for transcatheter aortic valve implantation (TAVI) procedures are ever-increasing, and there are many challenges that need to be considered in patients with concomitant severe AS and CKD being assessed for TAVI. Throughout the process of working these patients up for definitive management of their valvular heart disease, the presence of CKD impacts on diagnostic investigations, treatment decisions, and therapeutic interventions. Herein we review the current literature regarding TAVI in patients with CKD focusing on the decision-making process and specific risks involved in TAVI and CKD. We also provide specific practical strategies to best manage this challenging patient cohort.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
The Canadian journal of cardiology - 35(2019), 9 vom: 01. Sept., Seite 1188-1194 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hensey, Mark [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 04.05.2020 Date Revised 05.05.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cjca.2018.11.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM295326859 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM295326859 | ||
| 003 | DE-627 | ||
| 005 | 20231225083423.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cjca.2018.11.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0984.xml |
| 035 | |a (DE-627)NLM295326859 | ||
| 035 | |a (NLM)30910248 | ||
| 035 | |a (PII)S0828-282X(18)31284-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hensey, Mark |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of Chronic Kidney Disease on Decision Making and Management in Transcatheter Aortic Valve Interventions |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.05.2020 | ||
| 500 | |a Date Revised 05.05.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a The coexistence of chronic kidney disease (CKD) and severe aortic stenosis (AS) is common, and the prevalence of both is rising. The 2 conditions are inherently linked in that significant CKD may accelerate the development of AS and severe AS may result in deteriorating kidney function. The volume of and indications for transcatheter aortic valve implantation (TAVI) procedures are ever-increasing, and there are many challenges that need to be considered in patients with concomitant severe AS and CKD being assessed for TAVI. Throughout the process of working these patients up for definitive management of their valvular heart disease, the presence of CKD impacts on diagnostic investigations, treatment decisions, and therapeutic interventions. Herein we review the current literature regarding TAVI in patients with CKD focusing on the decision-making process and specific risks involved in TAVI and CKD. We also provide specific practical strategies to best manage this challenging patient cohort | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Murdoch, Dale J |e verfasserin |4 aut | |
| 700 | 1 | |a Sathananthan, Janarthanan |e verfasserin |4 aut | |
| 700 | 1 | |a Wood, David A |e verfasserin |4 aut | |
| 700 | 1 | |a Webb, John G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Canadian journal of cardiology |d 1993 |g 35(2019), 9 vom: 01. Sept., Seite 1188-1194 |w (DE-627)NLM012635553 |x 1916-7075 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2019 |g number:9 |g day:01 |g month:09 |g pages:1188-1194 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cjca.2018.11.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2019 |e 9 |b 01 |c 09 |h 1188-1194 | ||